Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 86


Immunity to Commensal Fungi: Detente and Disease.

Wheeler ML, Limon JJ, Underhill DM.

Annu Rev Pathol. 2017 Jan 24;12:359-385. doi: 10.1146/annurev-pathol-052016-100342. Epub 2016 Dec 21. Review.


Performance Evaluation and Community Application of Low-Cost Sensors for Ozone and Nitrogen Dioxide.

Duvall RM, Long RW, Beaver MR, Kronmiller KG, Wheeler ML, Szykman JJ.

Sensors (Basel). 2016 Oct 13;16(10). pii: E1698.


Hexokinase Is an Innate Immune Receptor for the Detection of Bacterial Peptidoglycan.

Wolf AJ, Reyes CN, Liang W, Becker C, Shimada K, Wheeler ML, Cho HC, Popescu NI, Coggeshall KM, Arditi M, Underhill DM.

Cell. 2016 Jul 28;166(3):624-636. doi: 10.1016/j.cell.2016.05.076. Epub 2016 Jun 30.


Immunological Consequences of Intestinal Fungal Dysbiosis.

Wheeler ML, Limon JJ, Bar AS, Leal CA, Gargus M, Tang J, Brown J, Funari VA, Wang HL, Crother TR, Arditi M, Underhill DM, Iliev ID.

Cell Host Microbe. 2016 Jun 8;19(6):865-73. doi: 10.1016/j.chom.2016.05.003. Epub 2016 May 26.


Depressive symptoms, antidepressant medication use, and new onset of diabetes in participants of the diabetes prevention program and the diabetes prevention program outcomes study.

Marrero DG, Ma Y, de Groot M, Horton ES, Price DW, Barrett-Connor E, Carnethon MR, Knowler WC; Diabetes Prevention Program Research Group.

Psychosom Med. 2015 Apr;77(3):303-10. doi: 10.1097/PSY.0000000000000156.


HIGD1A Regulates Oxygen Consumption, ROS Production, and AMPK Activity during Glucose Deprivation to Modulate Cell Survival and Tumor Growth.

Ameri K, Jahangiri A, Rajah AM, Tormos KV, Nagarajan R, Pekmezci M, Nguyen V, Wheeler ML, Murphy MP, Sanders TA, Jeffrey SS, Yeghiazarians Y, Rinaudo PF, Costello JF, Aghi MK, Maltepe E.

Cell Rep. 2015 Feb 12. pii: S2211-1247(15)00033-9. doi: 10.1016/j.celrep.2015.01.020. [Epub ahead of print]


APOBEC3 enzymes restrict marginal zone B cells.

Beck-Engeser GB, Winkelmann R, Wheeler ML, Shansab M, Yu P, Wünsche S, Walchhütter A, Metzner M, Vettermann C, Eilat D, DeFranco A, Jäck HM, Wabl M.

Eur J Immunol. 2015 Mar;45(3):695-704. doi: 10.1002/eji.201445218. Epub 2015 Jan 21.


Time to cast a larger net.

Wheeler ML, Underhill DM.

Nat Immunol. 2014 Nov;15(11):1000-1. doi: 10.1038/ni.3013. No abstract available.


Fat facts. should you eat less or more fat? Well it depends.

Wheeler ML.

Diabetes Forecast. 2014 Mar;67(3):62-3. No abstract available.


Diabetes autoantibodies do not predict progression to diabetes in adults: the Diabetes Prevention Program.

Dabelea D, Ma Y, Knowler WC, Marcovina S, Saudek CD, Arakaki R, White NH, Kahn SE, Orchard TJ, Goldberg R, Palmer J, Hamman RF; Diabetes Prevention Program Research Group.

Diabet Med. 2014 Sep;31(9):1064-8. doi: 10.1111/dme.12437. Epub 2014 Apr 9.


Circulating natriuretic peptide concentrations reflect changes in insulin sensitivity over time in the Diabetes Prevention Program.

Walford GA, Ma Y, Christophi CA, Goldberg RB, Jarolim P, Horton E, Mather KJ, Barrett-Connor E, Davis J, Florez JC, Wang TJ; Diabetes Prevention Program Research Group.

Diabetologia. 2014 May;57(5):935-9. doi: 10.1007/s00125-014-3183-2. Epub 2014 Feb 20.


Short and long-term lifestyle coaching approaches used to address diverse participant barriers to weight loss and physical activity adherence.

Venditti EM, Wylie-Rosett J, Delahanty LM, Mele L, Hoskin MA, Edelstein SL; Diabetes Prevention Program Research Group.

Int J Behav Nutr Phys Act. 2014 Feb 12;11:16. doi: 10.1186/1479-5868-11-16.


Common variation at PPARGC1A/B and change in body composition and metabolic traits following preventive interventions: the Diabetes Prevention Program.

Franks PW, Christophi CA, Jablonski KA, Billings LK, Delahanty LM, Horton ES, Knowler WC, Florez JC; Diabetes Prevention Program Research Group.

Diabetologia. 2014 Mar;57(3):485-90. doi: 10.1007/s00125-013-3133-4. Epub 2013 Dec 7.


Truth in advertising.

Wheeler ML, Dunbar S.

Diabetes Forecast. 2013 Sep;66(9):28, 31. No abstract available.


Diacylglycerol kinase ζ limits B cell antigen receptor-dependent activation of ERK signaling to inhibit early antibody responses.

Wheeler ML, Dong MB, Brink R, Zhong XP, DeFranco AL.

Sci Signal. 2013 Oct 15;6(297):ra91. doi: 10.1126/scisignal.2004189.


Impact of diagnosis of diabetes on health-related quality of life among high risk individuals: the Diabetes Prevention Program outcomes study.

Marrero D, Pan Q, Barrett-Connor E, de Groot M, Zhang P, Percy C, Florez H, Ackermann R, Montez M, Rubin RR; DPPOS Research Group.

Qual Life Res. 2014 Feb;23(1):75-88. doi: 10.1007/s11136-013-0436-3. Epub 2013 May 26.


Variety--the spice of life.

Wheeler ML.

Diabetes Forecast. 2013 Mar;66(3):64-6. No abstract available.


Confirming glycemic status in the Diabetes Prevention Program: implications for diagnosing diabetes in high risk adults.

Christophi CA, Resnick HE, Ratner RE, Temprosa M, Fowler S, Knowler WC, Shamoon H, Barrett-Connor E, Kahn SE; Diabetes Prevention Program Research Group.

J Diabetes Complications. 2013 Mar-Apr;27(2):150-7. doi: 10.1016/j.jdiacomp.2012.09.012. Epub 2012 Nov 7.


Prolonged production of reactive oxygen species in response to B cell receptor stimulation promotes B cell activation and proliferation.

Wheeler ML, Defranco AL.

J Immunol. 2012 Nov 1;189(9):4405-16. doi: 10.4049/jimmunol.1201433. Epub 2012 Sep 28.


Effects of genetic variants previously associated with fasting glucose and insulin in the Diabetes Prevention Program.

Florez JC, Jablonski KA, McAteer JB, Franks PW, Mason CC, Mather K, Horton E, Goldberg R, Dabelea D, Kahn SE, Arakaki RF, Shuldiner AR, Knowler WC; Diabetes Prevention Program Research Group.

PLoS One. 2012;7(9):e44424. doi: 10.1371/journal.pone.0044424. Epub 2012 Sep 11.

Supplemental Content

Loading ...
Support Center